Posted On: October 27, 2009
AstraZeneca ordered to pay $14.7 million in drug price case
A jury has hit British drugmaker AstraZeneca with a $14.7 million verdict after finding that the company inflated its prescription drug prices for Medicaid reimbursement.
To read more about the $14.7 million drug price case.
